Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in relapsing-Remitting Multiple Sclerosis
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Significant Percentage of MS Patients Receiving Alemtuzumab in Genzyme’s Phase 2 Trial Remain Free of Clinically Active Disease
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
Sanofi MS drug nears green light after pass-the-parcel marathon
White matter astrocytes in health and disease.
A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Dynamic regulatory network controlling TH17 cell differentiation.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Sex-related factors in multiple sclerosis susceptibility and progression.
Rescue Therapy Using Rituximab for Multiple Sclerosis.
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
Novel therapies for memory cells in autoimmune diseases.
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.

Pages